Sichuan Kelun Pharmaceutical Co (SZSE:002422) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co Change In Receivables?

Sichuan Kelun Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sichuan Kelun Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sichuan Kelun Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥1,088 Mil. It means Sichuan Kelun Pharmaceutical Co's Accounts Receivable declined by ¥1,088 Mil from Dec. 2022 to Dec. 2023 .

Sichuan Kelun Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥4,970 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sichuan Kelun Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 72.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sichuan Kelun Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥523 Mil.

Sichuan Kelun Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co Change In Receivables Chart

Sichuan Kelun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-764.39

67.73

625.71

-905.52

1,088.25

Sichuan Kelun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Sichuan Kelun Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sichuan Kelun Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4969.552	/	6219.417	*	91
=	72.91

2. In Ben Graham's calculation of liquidation value, Sichuan Kelun Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Sichuan Kelun Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6830.891	-	11804.006	+	0.75 * 4969.552	+	0.5 * 3536.918
=	523

Sichuan Kelun Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071

Website

http://www.kelun.com

Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.

Executives

Lai De Gui	Executives
Feng Hao	Directors, executives
Liu Si Chuan	Directors, executives
Wang Jing Yi	Directors, executives
Wan Yang Yu	Executives
Ge Jun You	Executives
Wu Zhong Hua	Executives
Wan Peng	Supervisors
Tan Hong Bo	Executives
Liu Ge Xin	Director
Huang Xin	Securities Affairs Representative
Ge Tao	Executives
Pan Hui	Directors, executives
Zhou Xiao Dong	Executives
Zheng Chang Yan	Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines